Itau Unibanco Holding S.A.’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $75.2K | Sell |
348
-1
| -0.3% | -$191 | ﹤0.01% | 253 |
|
|
2026
Q1 | $64K | Buy |
349
+12
| +4% | +$2.21K | ﹤0.01% | 227 |
|
|
2025
Q4 | $59.3K | Buy |
337
+66
| +24% | +$10.8K | ﹤0.01% | 230 |
|
|
2025
Q3 | $38K | Sell |
271
-2
| -0.7% | -$270 | ﹤0.01% | 275 |
|
|
2025
Q2 | $34.3K | Sell |
273
-3
| -1% | -$374 | ﹤0.01% | 300 |
|
|
2025
Q1 | $38K | Hold |
276
| – | – | ﹤0.01% | 304 |
|
|
2024
Q4 | $42.2K | Buy |
276
+45
| +19% | +$7.59K | ﹤0.01% | 271 |
|
|
2024
Q3 | $44.8K | Buy |
231
+90
| +64% | +$18.8K | ﹤0.01% | 195 |
|
|
2024
Q2 | $32.7K | Buy |
+141
| New | +$30.6K | ﹤0.01% | 196 |
|
|
2024
Q1 | – | Sell |
-268
| Closed | -$69.3K | – | 153 |
|
|
2023
Q4 | $69.3K | Buy |
268
+59
| +28% | +$14.5K | ﹤0.01% | 198 |
|
|
2023
Q3 | $53.7K | Sell |
209
-1
| -0.5% | -$267 | ﹤0.01% | 267 |
|
|
2023
Q2 | $59.8K | Sell |
210
-1
| -0.5% | -$298 | ﹤0.01% | 310 |
|
|
2023
Q1 | $58.7K | Hold |
211
| – | – | ﹤0.01% | 331 |
|
|
2022
Q4 | $58.4K | Sell |
211
-7
| -3% | -$1.98K | ﹤0.01% | 336 |
|
|
2022
Q3 | $58K | Sell |
218
-109
| -33% | -$23.1K | ﹤0.01% | 374 |
|
|
2022
Q2 | $67K | Sell |
327
-3
| -0.9% | -$613 | ﹤0.01% | 315 |
|
|
2022
Q1 | $69K | Buy |
330
+3
| +0.9% | +$652 | ﹤0.01% | 289 |
|
|
2021
Q4 | $78K | Buy |
327
+105
| +47% | +$27K | ﹤0.01% | 244 |
|
|
2021
Q3 | $63K | Buy |
222
+77
| +53% | +$25.2K | ﹤0.01% | 240 |
|
|
2021
Q2 | $50K | Buy |
+145
| New | +$43.9K | ﹤0.01% | 169 |
|
|
2020
Q2 | – | Sell |
-280
| Closed | -$89K | – | 170 |
|
|
2020
Q1 | $89K | Sell |
280
-514
| -65% | -$156K | 0.01% | 138 |
|
|
2019
Q4 | $236K | Buy |
+794
| New | +$220K | 0.01% | 191 |
|
|
2019
Q3 | – | Sell |
-1,866
| Closed | -$436K | – | 342 |
|
|
2019
Q2 | $436K | Buy |
1,866
+1,280
| +218% | +$296K | 0.02% | 334 |
|
|
2019
Q1 | $171K | Hold |
586
| – | – | 0.01% | 217 |
|
|
2018
Q4 | $171K | Sell |
586
-172
| -23% | -$54.9K | 0.01% | 217 |
|
|
2018
Q3 | $268K | Sell |
758
-846
| -53% | -$291K | 0.02% | 207 |
|
|
2018
Q2 | $466K | Sell |
1,604
-2,795
| -64% | -$786K | 0.05% | 117 |
|
|
2018
Q1 | $1.21M | Buy |
4,399
+1,470
| +50% | +$456K | 0.01% | 106 |
|
|
2017
Q4 | $933K | Buy |
2,929
+120
| +4% | +$38.5K | 0.06% | 92 |
|
|
2017
Q3 | $2.78M | Buy |
2,809
+2,361
| +527% | +$699K | 0.19% | 57 |
|
|
2017
Q2 | $121K | Buy |
448
+299
| +201% | +$79.1K | 0.01% | 218 |
|
|
2017
Q1 | $41K | Sell |
149
-211
| -59% | -$59.7K | ﹤0.01% | 245 |
|
|
2016
Q4 | $101K | Buy |
360
+70
| +24% | +$20.8K | 0.01% | 121 |
|
|
2016
Q3 | $91K | Buy |
+290
| New | +$85.9K | 0.01% | 153 |
|
Other funds holding BIIB
Itau Unibanco Holding S.A.'s BIIB Position: Q2 2026 in Review
Itau Unibanco Holding S.A. reduced its Biogen (BIIB) stake by 0.29% in Q2 2026, selling an estimated $191 and leaving 348 shares worth $75.2K. The position accounts for ﹤0.01% of the portfolio, ranked #253.
Itau Unibanco Holding S.A. first reported a position in BIIB in Q3 2016 and has held it in 34 quarters since. The position peaked at $2.78M in Q3 2017. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Itau Unibanco Holding S.A. held 348 shares of Biogen worth $75.2K as of Q2 2026.
- Itau Unibanco Holding S.A. sold 1 Biogen share in Q2 2026, an estimated $191.
- Biogen made up ﹤0.01% of Itau Unibanco Holding S.A.'s portfolio in Q2 2026, its #253 holding.
- Itau Unibanco Holding S.A. first reported a position in Biogen in Q3 2016 and has held it in 34 quarters since.
- Itau Unibanco Holding S.A.'s Biogen position peaked at $2.78M in Q3 2017.
- 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Itau Unibanco Holding S.A.'s 13F filing for Q2 2026, filed 14 Aug 2026.